Literature DB >> 8881680

Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.

V Goulden1, M J Goodfield.   

Abstract

We report a 7-year-old girl with extensive toxic epidermal necrolysis (TEN) and neutropenia who was successfully treated using recombinant granulocyte colony-stimulating factor. Our patient had extensive epidermal loss and neutropenia, both indicators of a poor prognosis, but none the less made a rapid and complete recovery.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8881680

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

2.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 3.  Drug induced exfoliative dermatitis: state of the art.

Authors:  Mona-Rita Yacoub; Alvise Berti; Corrado Campochiaro; Enrico Tombetti; Giuseppe Alvise Ramirez; Andrea Nico; Elisabetta Di Leo; Paola Fantini; Maria Grazia Sabbadini; Eustachio Nettis; Giselda Colombo
Journal:  Clin Mol Allergy       Date:  2016-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.